产品经理/主管

Chinese protein technology company founded in November 2020 and based in Shanghai, focused on applications of proteins in biopharmaceuticals and other fields, with a technical team of returnee doctorate and masters holders experienced in industrialisation. Designs complex protein structures and functions using its own computer simulation and high throughput screening platforms to produce high quality, hard to copy and highly stable protein raw materials, and has developed close to two hundred high end protein materials used in new drug research including antibody drug conjugates, diagnostics, vaccines and cell therapy. Runs protein technology laboratories, innovative diagnostic product laboratories and a GMP pilot production platform in Shanghai, Suzhou and Beijing, and has raised several hundred million yuan across three funding rounds from investors including CDH Investments, Gaorong Capital and Fosun Rongxing.